Creation of human tumour cells with defined genetic elements
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
During malignant transformation, cancer cells acquire genetic mutations that override the normal mechanisms controlling cellular proliferation. Primary rodent cells are efficiently converted into tumorigenic cells by the coexpression of cooperating oncogenes. However, similar experiments with human cells have consistently failed to yield tumorigenic transformants, indicating a fundamental difference in the biology of human and rodent cells. The few reported successes in the creation of human tumour cells have depended on the use of chemical or physical agents to achieve immortalization, the selection of rare, spontaneously arising immortalized cells, or the use of an entire viral genome. We show here that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination with two oncogenes (the simian virus 40 large-T oncoprotein and an oncogenic allele of H-ras) results in direct tumorigenic conversion of normal human epithelial and fibroblast cells. These results demonstrate that disruption of the intracellular pathways regulated by large-T, oncogenic ras and telomerase suffices to create a human tumor cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of telomerase in conjunction with expression of simian virus 40 large T oncoprotein and an oncogenic allele of H-ras has been shown to promote tumorigenic conversion of normal human cells (28).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [28]
In the citing paper
“Interestingly, high telomerase expression, which is associated with long telomeres, is commonly found in adult stem/progenitor cell compartments, including the stem cells in hair follicles, whereas low telomerase expression has been detected in human fibroblasts and epithelial cells [115, 116].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [116]
In the citing paper
“In studies employing a p53 allele (R172P) capable of enforcing senescence but defective in apoptosis, dysfunctional telomeres strongly inhibited the spontaneous lymphomas and sarcomas to which p53-mutant mice normally succumb.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“However, the R172P allele was not as efficient as wild-type p53 in inhibiting chemically induced papillomas”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“suggesting that senescence was insufficient to block transformation of keratinocytes in this model (94).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Self-citationA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Kim, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2595 · Cited by 686
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
Research works printed but not linked: 1
- Kang, J.-S.et al. Involvement of tyrosine phosphorylation of p185c-erb/neu in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinogen.21, 225–233 (1998). · DOI
Cited by
Items 501–600 of 1,011
Lindvall, C. J., Hou, M., Komurasaki, T., Zheng, C., Arsenian‐Henriksson, M., Sedivy, J. M., Björkholm, M., Teh, B. T., Nordenskjöld, M., & Xu, D. (2003) · PubMed · Cited by 106
Kitagawa, M., Tahara, H., Kitagawa, S., Oka, H., Kudo, Y., Sato, S., Ogawa, I., Miyaichi, M., & Takata, T. (2006) · Bone · doi:10.1016/j.bone.2006.05.022 · Cited by 100
Telomere instability and cancer
Londoño‐Vallejo, A. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.009 · Cited by 104
Opitz, O. G., Suliman, Y., Hahn, W. C., Harada, H., Blum, H. E., & Rustgi, A. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11909 · Cited by 99
Self-citationDomchek, S. M., Recio, A., Mick, R., Clark, C. E., Carpenter, E. L., Fox, K. R., DeMichele, A. M., Schuchter, L. M., Leibowitz, M. S., Wexler, M. H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2765 · Cited by 108
Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development
Siegel, D. H., Mann, J. A., Krol, A. L., & Rauen, K. A. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10744.x · Cited by 98
Cancer genome sequencing: The challenges ahead
Heng, H. H. (2007) · BioEssays · doi:10.1002/bies.20610 · Cited by 106
Lu, Z., Hornia, A., Joseph, T., Sukezane, T., Frankel, P., Zhong, M., Bychenok, S., Xu, L., Feig, L. A., & Foster, D. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.462-467.2000 · Cited by 98
How many mutations does it take to make a tumor?
Boland, C. R., & Ricciardiello, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14675 · Cited by 98
Saretzki, G. C., Ludwig, A., von Zglinicki, T., & Runnebaum, I. B. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700383 · Cited by 109
Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells.
Hamid, T., Malik, M. T., & Kakar, S. S. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-3 · Cited by 102
Adenovirus E1B 55-Kilodalton Oncoprotein Inhibits p53 Acetylation by PCAF
Liu, Y., Colosimo, A. L., Yang, X.-J., & Liao, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5540-5553.2000 · Cited by 97
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
“This knowledge further culminated in the identification of PP2A as a major tumor suppressive phosphatase whose inactivation was one of five defined alterations and prerequisites to transform several normal human epithelial cell types into fully malignant cells (10-12).”
BackgroundZhang, Y., Xu, Y., Lu, W., Ghergurovich, J. M., Guo, L., Blair, I. A., Rabinowitz, J. D., & Yang, X. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.002 · Cited by 96
The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas.
Polsky, D., Young, A. Z., BUSAM, K. J., & Alani, R. M. (2001) · PubMed · Cited by 116
Biological mechanism profiling using an annotated compound library
Root, D. E., Flaherty, S. P., Kelley, B. P., & Stockwell, B. R. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.08.009 · Cited by 95
Glioblastoma Angiogenesis and Tumor Cell Invasiveness Are Differentially Regulated by β8 Integrin
Tchaicha, J. H., Reyes, S. B., Shin, J., Hossain, M. G., Lang, F. F., & McCarty, J. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0991 · Cited by 103
de Oliveira, D. E. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.05.010 · Cited by 113
González-Suárez, E., Flores, J. M., & Blasco, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7291-7301.2002 · Cited by 95
Pendino, F., Flexor, M., Delhommeau, F., Selimoglu‐Buet, D., Lanotte, M., & Ségal-Bendirdjian, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111464998 · Cited by 103
Piunti, A., Rossi, A., Cerutti, A., Albert, M., Jammula, S., Scelfo, A., Cedrone, L., Fragola, G., Olsson, L., Koseki, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms4649 · Cited by 93
Brümmendorf, T. H., & Balabanov, S. (2006) · Leukemia · doi:10.1038/sj.leu.2404339 · Cited by 102
Telomerase: regulation, function and transformation
Dong, C. K., Masutomi, K., & Hahn, W. C. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.12.005 · Cited by 100
Self-citationThe significance of telomerase activation and cellular immortalization in human cancer
Newbold, R. F. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.539 · Cited by 100
Dajee, M., Tarutani, M., Deng, H., Cai, T., & Khavari, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205287 · Cited by 104
Villa, R., Folini, M., Lualdi, S., Veronese, S. M., Daidone, M. G., & Zaffaroni, N. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01540-4 · Cited by 102
Drayton, S., Rowe, J., Jones, R., Vatcheva, R., Heavens, D., Marshall, J. F., Fried, M., & Peters, G. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00242-3 · Cited by 98
Willets, R., Gallop, A., Leandro, P. A., Lu, J. L. C., Macdonald, A. S., Miller, K. A., Richards, S. J., Robjohns, N., Ryan, J. P., & Waters, H. R. (2004) · British Actuarial Journal · doi:10.1017/s1357321700002750 · Cited by 108
Adhikari, H., & Counter, C. M. (2018) · Nature Communications · doi:10.1038/s41467-018-05692-6 · Cited by 91
Self-citationInhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest
Yang, W. S., & Stockwell, B. R. (2008) · Genome Biology · doi:10.1186/gb-2008-9-6-r92 · Cited by 93
Telomeres and telomerase as targets for anticancer drug development
Olaussen, K. A., Dubrana, K., Dômont, J., Spano, J., Sabatier, L., & Soria, J. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.08.007 · Cited by 108
Di Nicolantonio, F., Arena, S., Gallicchio, M., Zecchin, D., Martini, M., Flonta, S. E., Stella, G. M., Lamba, S., Cancelliere, C., Russo, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808757105 · Cited by 92
MacKenzie, K. L., Franco, S., May, C., Sadelain, M., & Moore, M. A. S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4982 · Cited by 92
The Evolving Portrait of Cancer Metastasis
GUPTA, P. B., MANI, S., YANG, J., HARTWELL, K., & WEINBERG, R. A. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.033 · Cited by 92
Self-citationWood, L. D., Halvorsen, T. L., Dhar, S., Baur, J. A., Pandita, R. K., Wright, W. E., Hande, M. P., Calaf, G., Hei, T. K., Levine, F., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204072 · Cited by 91
Prognostic relevance of altered Fas (CD95)-system in human breast cancer
Mottolese, M., Buglioni, S., Bracalenti, C., Cardarelli, M. A., Ciabocco, L., Giannarelli, D., Botti, C., Natali, P. G., Concetti, A., & Venanzi, F. M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<198::aid-ijc16>3.0.co;2-l · Cited by 105
Molecular Biology for the Radiation Oncologist: the 5Rs of Radiobiology meet the Hallmarks of Cancer
Harrington, K. J., Jankowska, P., & Hingorani, M. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.04.009 · Cited by 115
Cellular Senescence and Tissue Aging In Vivo
Hornsby, P. J. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b251 · Cited by 91
BRCA1 Inhibition of Telomerase Activity in Cultured Cells
Xiong, J., Fan, S., Meng, Q., Schramm, L., Wang, C., Bouzahza, B., Zhou, J., Zafonte, B. T., Goldberg, I. D., Haddad, B. R., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8668-8690.2003 · Cited by 110
Soejima, K., Fang, W., & Rollins, B. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206510 · Cited by 91
Zhao, Q., Lei, P., Zhang, X., Zheng, J., Wang, H.-Y., Zhao, J., Li, Y., Ye, M., Li, L., Wei, G., et al. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0201-x · Cited by 99
A large-scale targeted proteomics assay resource based on an in vitro human proteome
Matsumoto, M., Matsuzaki, F., Oshikawa, K., Goshima, N., Mori, M., Kawamura, Y., Ogawa, K., Fukuda, E., Nakatsumi, H., Natsume, T., et al. (2016) · Nature Methods · doi:10.1038/nmeth.4116 · Cited by 105
Hagerling, C., Owyong, M., Sitarama, V., Wang, C., Lin, C., van den Bijgaart, R. J. E., Koopman, C. D., Brenot, A., Nanjaraj, A., Wärnberg, F., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06986-z · Cited by 93
Sphingolipids in cancer: Regulation of pathogenesis and therapy
Öğretmen, B. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.052 · Cited by 90
Fujii, S., Maeda, H., Wada, N., Kano, Y., & Akamine, A. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0101-4 · Cited by 97
The role of Raf kinases in malignant transformation
Kölch, W., Kotwaliwale, A., Vass, K., & Janosch, P. (2002) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399402004386 · Cited by 91
Telomerase and its potential for therapeutic intervention
Phatak, P., & Burger, A. M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707374 · Cited by 90
Ras redux: rethinking how and where Ras acts
Hingorani, S. R., & Tuveson, D. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00017-5 · Cited by 103
Telomere Maintenance as a Target for Drug Discovery
Sekaran, V. G., Soares, J., & Jarstfer, M. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400528t · Cited by 97
RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection
Radenbaugh, A. J., Ma, S., Ewing, A., Stuart, J. M., Collisson, E. A., Zhu, J., & Haussler, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111516 · Cited by 89
Human PGBD5 DNA transposase promotes site-specific oncogenic mutations in rhabdoid tumors
Henssen, A. G., Koche, R. P., Zhuang, J., Jiang, E., Reed, C., Eisenberg, A., Still, E., MacArthur, I. C., Rodríguez-Fos, E., González, S., et al. (2017) · Klinische Pädiatrie · doi:10.1038/ng.3866 · Cited by 95
Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas, M. A., Reis, R. J. S., Akiyama, M., Koley, H., Chauhan, D., Hideshima, T., Goyal, R. K., Hurley, L. H., Anderson, K. C., & Munshi, N. C. (2003) · PubMed · Cited by 102
IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways
Benatar, T., Yang, W., Amemiya, Y., Evdokimova, V., Kahn, H., Holloway, C., & Seth, A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1816-4 · Cited by 89
“Mutations in RAS family members promote both proliferation and tumorigenesis in mammalian cells and occur in approximately 30% of human cancers [28–31].”
BackgroundKonishi, H., Karakas, B., Abukhdeir, A. M., Lauring, J., Gustin, J. P., Garay, J. P., Konishi, Y., Gallmeier, E., Bachman, K. E., & Park, B. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0108 · Cited by 89
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa, K. L., Boulay, A., Masson, R., Mathelin, C., Stoll, I., Tomasetto, C., Chenard, M., Gintz, M., Bellocq, J., & Rio, M. (2003) · PubMed · Cited by 104
Flanagan, J. M., Funes, J. M., Henderson, S. R., Wild, L., Carey, N., & Boshoff, C. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0636 · Cited by 87
Cheng, E., Zhang, X., Wilson, K., Wang, D. H., Park, J. Y., Huo, X., Yu, C.-H., Zhang, Q.-Y., Spechler, S., & Souza, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157376 · Cited by 85
Glioma stem cells: Evidence and limitation
Fan, X., Salford, L. G., & Widegren, B. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.04.002 · Cited by 87
Senescence and immortality in hepatocellular carcinoma
Öztürk, M., Arslan-Ergül, A., Baǧışlar, S., Şentürk, Ş., & Yuzugullu, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.048 · Cited by 103
Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts
Loghman‐Adham, M., Nauli, S. M., Soto, C. E., Kariuki, B., & Zhou, J. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00310.2002 · Cited by 88
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100422 · Cited by 90
Generating trunk neural crest from human pluripotent stem cells
Huang, M., Miller, M. L., McHenry, L. K., Zheng, T., Zhen, Q., Ilkhanizadeh, S., Conklin, B. R., Bronner-Fraser, M. E., & Weiss, W. A. (2016) · Scientific Reports · doi:10.1038/srep19727 · Cited by 92
The potential of organoids in urological cancer research
Wang, S., Gao, D., & Chen, Y. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.65 · Cited by 87
Metabolic Dependencies in Pancreatic Cancer
Vaziri-Gohar, A., Zarei, M., Brody, J. R., & Winter, J. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00617 · Cited by 87
Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
Braiterman, L., Nyasae, L., Guo, Y., Bustos, R., Lutsenko, S., & Hubbard, A. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90489.2008 · Cited by 87
Vecchio, G., Galeone, A., Brunetti, V., Maiorano, G., Sabella, S., Cingolani, R., & Pompa, P. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029980 · Cited by 98
Epstein–Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation
Hu, H., Luo, M., Desmedt, C., Nabavi, S., Yadegarynia, S., Hong, A., Konstantinopoulos, P. A., Gabrielson, E., Hines‐Boykin, R., Pihan, G. A., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.05.025 · Cited by 93
Immortalization of chicken preadipocytes by retroviral transduction of chicken TERT and TR
Wang, W., Zhang, T., Wu, C., Wang, S., Wang, Y., Li, H., & Wang, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177348 · Cited by 101
Review Article: The Role of Ras Superfamily Proteins in Bladder Cancer Progression
OXFORD, G., & THEODORESCU, D. (2003) · Journal of Urology · doi:10.1097/01.ju.0000088670.02905.78 · Cited by 86
van Haaften, G. W., Romeijn, R. J., Pothof, J., Koole, W., Mullenders, L. H. F., Pastink, A., Plasterk, R. H. A., & Tijsterman, M. (2006) · Current Biology · doi:10.1016/j.cub.2006.05.047 · Cited by 99
Grignani, F., Valtieri, M., Gabbianelli, M., Gelmetti, V., Botta, R., Luchetti, L., Masella, B., Morsilli, O., Pelosi, E., Samoggia, P., et al. (2000) · Blood · doi:10.1182/blood.v96.4.1531 · Cited by 89
Genetic and Epigenetic Changes in Mammary Epithelial Cells May Mimic Early Events in Carcinogenesis
Tlsty, T. D., Crawford, Y., Holst, C. R., Fordyce, C., Zhang, J., McDermott, K. M., Kozakiewicz, K., & Gauthier, M. L. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048773.95897.5f · Cited by 89
Molecular pathogenesis of thyroid cancer
Segev, D. L., Umbricht, C. B., & Zeiger, M. A. (2003) · Surgical Oncology · doi:10.1016/s0960-7404(03)00037-9 · Cited by 107
From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens
Schultze, J. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02015-4 · Cited by 86
Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us
Tekle, G. E., Bernasocchi, T., Unni, A. M., Bertoni, F., Rossi, D., Rubin, M. A., & Theurillat, J.-P. P. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.04.009 · Cited by 93
Organoids as Models for Neoplastic Transformation
Neal, J. T., & Kuo, C. J. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044249 · Cited by 84
Genetic Modeling of Human Rhabdomyosarcoma
Linardic, C. M., Downie, D. L., Qualman, S. J., Bentley, R. C., & Counter, C. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3194 · Cited by 93
Self-citationDefining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
Naini, S., Etheridge, K. T., Adam, S. J., Qualman, S. J., Bentley, R. C., Counter, C. M., & Linardic, C. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6178 · Cited by 85
Self-citationDo tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence?
Pelicci, P. G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420750 · Cited by 85
The use of telomerized cells for tissue engineering
Shay, J. W., & Wright, W. E. (2000) · Nature Biotechnology · doi:10.1038/71872 · Cited by 85
Extensive somatic microsatellite mutations in normal human tissue.
Vilkki, S., Tsao, J., Loukola, A., Pöyhönen, M., Vierimaa, O., Herva, R., Aaltonen, L. A., & Shibata, D. K. (2001) · PubMed · Cited by 92
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray
Hedberg, Y., Ljungberg, B., Roos, G., & Landberg, G. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600922 · Cited by 85
Masutomi, K., Kaneko, S., Hayashi, N., Yamashita, T., Shirota, Y., Kobayashi, K., & Murakami, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000622200 · Cited by 85
The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activation
Grasso, M. J., Bond, G. J., Kim, Y., Boyd, S. D., Dzebo, M. M., Dzebo, M. M., Valenzuela, S., Schibrowsky, N. A., Alwan, K. B., Blackburn, N. J., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101314 · Cited by 87
Xie, G., Cheng, K., Shant, J., & Raufman, J. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90519.2008 · Cited by 93
Cancer progression by non‐clonal chromosome aberrations
Heng, H. H., Bremer, S. W., Stevens, J. B., Ye, K. J., Miller, F. W., Liu, G., & Ye, C. J. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20964 · Cited by 84
The stem cell division theory of cancer
López‐Lázaro, M. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.01.010 · Cited by 111
Niemelä, M., Kauko, O., Sihto, H., Mpindi, J.-P., Nicorici, D., Pernilä, P., Kallioniemi, O.-P., Joensuu, H., Hautaniemi, S., & Westermarck, J. (2012) · Oncogene · doi:10.1038/onc.2011.599 · Cited by 79
Cyclo[n]pyrroles: Size and Site-Specific Binding to G-Quadruplexes
Baker, E. S., Lee, J. T., Sessler, J. L., & Bowers, M. T. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0564968 · Cited by 89
Immortalization and Transformation of Human Cells
C. Hahn, W. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15045-x · Cited by 84
Self-citationBrassart, B., Gómez, D., Cian, A. D., Boujemaa‐Paterski, R., Montagnac, A., Khuong‐Huu, Q., Temime‐Smaali, N., Trentesaux, C., Mergny, J., Guéritte, F., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.036574 · Cited by 87
Bocchetta, M., Eliasz, S., Marco, M. A. D., Rudzinski, J., Zhang, L., & Carbone, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5203 · Cited by 105
Telomerase in alveolar epithelial development and repair
Driscoll, B., Buckley, S., Bui, K. C., Anderson, K. D., & Warburton, D. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1191 · Cited by 83
Chromosome‐mediated alterations of the MYC gene in human cancer
Popescu, N. C., & Zimonjic, D. B. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00183.x · Cited by 83
Strickler, H. D. (2001) · PubMed · Cited by 82
Singh, A. K., Sharma, N., Ghosh, M., Park, Y. H., & Jeong, D. K. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1129310 · Cited by 84
Wang, L., Soria, J., Kemp, B. L., Liu, D. D., Mao, L., & Khuri, F. R. (2002) · PubMed · Cited by 95
Alam, G. N., Cui, H., Shi, H., Yang, L., Ding, J., Mao, L., Maltese, W. A., & Ding, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090019 · Cited by 83
Metadata
- Authors
- Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 1999-07-29
- Volume
- 400
- Issue
- 6743
- Pages
- 464-468
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1545398558
- Cited by
- 2,345
- References
- 31
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 28 · 2023: 42 · 2022: 36 · 2021: 51 · 2020: 44 · 2019: 55 · 2018: 57 · 2017: 48 · 2016: 72 · 2015: 84 · 2014: 92 · 2013: 98 · 2012: 82
- FWCI
- 85.16
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2026-04-15)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- malignant transformation, telomerase reverse transcriptase, SV40 large T antigen, oncogene cooperation, cell immortalization, human epithelial cells, human fibroblasts
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Adhesion, Cell Division, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, DNA-Binding Proteins, Epithelial Cells, Fibroblasts, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Genes, ras, RNA, Telomere, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.